Theralase Technologies Inc. (TSXV:TLT)

Theralase Technologies Revenue

Theralase Technologies had revenue of 164.29K CAD in the quarter ending June 30, 2026, a decrease of -25.23%. This brings the company's total for the last twelve months to 802.46K, down -24.86% year-over-year. In the year 2025, Theralase Technologies had annual revenue of 816.47K, down -20.99%. That makes Theralase Technologies the 44,394th largest company in the world by revenue and 947th in Canada.

• Revenue (ttm): 802.46K
• Revenue Growth: -24.86%
• P/S Ratio: 69.64
• Revenue / Employee: 40.12K
• Employees: 20
• Market Cap: 57.44M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Canada 763.71K 93.5%
• United States of America (USA) 46.53K 5.7%
• International 6.22K 0.8%

Fiscal year ended Dec 31, 2025 See the full Theralase Technologies breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	816.47K	-216.96K	-20.99%
Dec 31, 2024	1.03M	-36.88K	-3.45%
Dec 31, 2023	1.07M	-68.26K	-6.00%
Dec 31, 2022	1.14M	357.93K	45.85%
Dec 31, 2021	780.64K	-148.48K	-15.98%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error